AI analysis of tumor scans for solid cancer patients
Part of Cancer, Digestive system clinical trials.
This trial uses artificial intelligence to analyze CT and MRI scans of solid tumors. The goal is to better understand how tumors respond to non-surgical treatments, which could help doctors make more personalized treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with a solid tumor (a cancer that forms a lump, not a blood cancer).
- You have received or will receive treatment that is not surgery (like chemotherapy, radiation, or immunotherapy).
- You have a CT or MRI scan taken before starting treatment and at least one follow-up scan.
- You are willing to let the researchers use your medical data and any stored samples for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to analyze imaging and tumor data from patients with hepatocellular carcinoma (liver cancer) being treated with a combination of TACE (a minimally invasive procedure), immunotherapy, and targeted therapy. The goal is to better predict which patients will respond well to treatment.
This trial uses artificial intelligence to analyze MRI scans from people diagnosed with a type of brain tumor called glioma. It aims to better understand the cancer from diagnosis through treatment, which could help guide future care.
This study uses artificial intelligence to analyze electronic health records (including medical history, lab results, and imaging data) to improve cancer diagnosis and prediction. It aims to help identify cancer earlier and more accurately, potentially leading to better treatment outcomes.
This study uses artificial intelligence to look at CT scans you've already had (without dye) to try and find signs of several types of cancer early. It may help find cancer sooner when it's easier to treat.
This study tests whether artificial intelligence (AI) can help doctors spot early signs of cancer (breast, liver, kidney, or bladder) on routine CT scans that patients get for other reasons. The goal is to see if this 'opportunistic screening' catches cancers earlier when they may be easier to treat.
This trial uses a computer to analyze CT scans taken before colon cancer surgery. The goal is to see if artificial intelligence can help doctors choose the best treatment for each patient.
Hear when a new Solid Tumor Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.